149 related articles for article (PubMed ID: 25879372)
21. Comparative effectiveness of generic and brand-name statins on patient outcomes: a cohort study.
Gagne JJ; Choudhry NK; Kesselheim AS; Polinski JM; Hutchins D; Matlin OS; Brennan TA; Avorn J; Shrank WH
Ann Intern Med; 2014 Sep; 161(6):400-7. PubMed ID: 25222387
[TBL] [Abstract][Full Text] [Related]
22. Association of polypharmacy and statin new-user adherence in a Veterans Health Administration population: a retrospective cohort study.
Watanabe JH; Bounthavong M; Chen T; Ney JP
Ann Pharmacother; 2013 Oct; 47(10):1253-9. PubMed ID: 24259688
[TBL] [Abstract][Full Text] [Related]
23. Factors influencing adherence in long-term use of statins.
Warren JR; Falster MO; Fox D; Jorm L
Pharmacoepidemiol Drug Saf; 2013 Dec; 22(12):1298-307. PubMed ID: 24105731
[TBL] [Abstract][Full Text] [Related]
24. Does a single-pill antihypertensive/lipid-lowering regimen improve adherence in US managed care enrolees? A non-randomized, observational, retrospective study.
Hussein MA; Chapman RH; Benner JS; Tang SS; Solomon HA; Joyce A; Foody JM
Am J Cardiovasc Drugs; 2010; 10(3):193-202. PubMed ID: 20387911
[TBL] [Abstract][Full Text] [Related]
25. The association between achieving low-density lipoprotein cholesterol (LDL-C) goal and statin treatment in an employee population.
Burton WN; Chen CY; Schultz AB; Edington DW
Popul Health Manag; 2010 Feb; 13(1):1-8. PubMed ID: 20158317
[TBL] [Abstract][Full Text] [Related]
26. Impact of hospitalization on medication adherence estimation in claims data.
Dong YH; Choudhry NK; Krumme A; Lee MP; Wu LC; Lai MS; Gagne JJ
J Clin Pharm Ther; 2017 Jun; 42(3):318-328. PubMed ID: 28370404
[TBL] [Abstract][Full Text] [Related]
27. Compliance and persistence with concomitant statin and oral antihyperglycemic therapy.
Zhang Q; Zhao C; Davies MJ; Radican L; Seck T
Am J Manag Care; 2011 Nov; 17(11):746-52. PubMed ID: 22084894
[TBL] [Abstract][Full Text] [Related]
28. Effect of statin adherence on cerebrovascular disease in primary prevention.
Perreault S; Ellia L; Dragomir A; Côté R; Blais L; Bérard A; Lalonde L
Am J Med; 2009 Jul; 122(7):647-55. PubMed ID: 19559167
[TBL] [Abstract][Full Text] [Related]
29. Statins reduce new-onset atrial fibrillation in a first-time myocardial infarction population: a nationwide propensity score-matched study.
Bang CN; Gislason GH; Greve AM; Torp-Pedersen C; Køber L; Wachtell K
Eur J Prev Cardiol; 2014 Mar; 21(3):330-8. PubMed ID: 23012689
[TBL] [Abstract][Full Text] [Related]
30. Medication adherence and readmission after myocardial infarction in the Medicare population.
Zhang Y; Kaplan CM; Baik SH; Chang CC; Lave JR
Am J Manag Care; 2014; 20(11):e498-505. PubMed ID: 25651604
[TBL] [Abstract][Full Text] [Related]
31. Association between copayment and adherence to statin treatment initiated after coronary heart disease hospitalization: a longitudinal, retrospective, cohort study.
Ye X; Gross CR; Schommer J; Cline R; St Peter WL
Clin Ther; 2007 Dec; 29(12):2748-57. PubMed ID: 18201593
[TBL] [Abstract][Full Text] [Related]
32. Does good medication adherence really save payers money?
Stuart BC; Dai M; Xu J; Loh FH; S Dougherty J
Med Care; 2015 Jun; 53(6):517-23. PubMed ID: 25961659
[TBL] [Abstract][Full Text] [Related]
33. Impact of concurrent medication use on statin adherence and refill persistence.
Grant RW; O'Leary KM; Weilburg JB; Singer DE; Meigs JB
Arch Intern Med; 2004 Nov; 164(21):2343-8. PubMed ID: 15557413
[TBL] [Abstract][Full Text] [Related]
34. Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel.
Chodick G; Shalev V; Gerber Y; Heymann AD; Silber H; Simah V; Kokia E
Clin Ther; 2008 Nov; 30(11):2167-79. PubMed ID: 19108805
[TBL] [Abstract][Full Text] [Related]
35. Drug utilization patterns and cardiovascular outcomes in elderly patients newly initiated on atorvastatin or simvastatin.
Swindle JP; Potash J; Kulakodlu M; Kuznik A; Buikema A
Am J Geriatr Pharmacother; 2011 Dec; 9(6):471-82. PubMed ID: 22019005
[TBL] [Abstract][Full Text] [Related]
36. Older statin initiators in Finland - cardiovascular risk profiles and persistence of use.
Upmeier E; Korhonen MJ; Rikala M; Helin-Salmivaara A; Huupponen R
Cardiovasc Drugs Ther; 2014 Jun; 28(3):263-72. PubMed ID: 24692150
[TBL] [Abstract][Full Text] [Related]
37. Adherence to statins and LDL-cholesterol goal attainment.
Chi MD; Vansomphone SS; Liu IL; Cheetham C; Green KR; Scott RD; Reynolds K
Am J Manag Care; 2014 Apr; 20(4):e105-12. PubMed ID: 24884955
[TBL] [Abstract][Full Text] [Related]
38. Compliance after switching from branded to generic statins.
Romanelli RJ; Jukes T; Segal JB
Pharmacoepidemiol Drug Saf; 2014 Oct; 23(10):1093-100. PubMed ID: 24817435
[TBL] [Abstract][Full Text] [Related]
39. Medication adherence with disease modifying treatments for multiple sclerosis among US employees.
Kleinman NL; Beren IA; Rajagopalan K; Brook RA
J Med Econ; 2010; 13(4):633-40. PubMed ID: 20958113
[TBL] [Abstract][Full Text] [Related]
40. Self-reported adherence by MARS-CZ reflects LDL cholesterol goal achievement among statin users: validation study in the Czech Republic.
Ladova K; Matoulkova P; Zadak Z; Macek K; Vyroubal P; Vlcek J; Morisky DE
J Eval Clin Pract; 2014 Oct; 20(5):671-7. PubMed ID: 24917035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]